Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum MindBio Therapeutics Corp C.MBIO

MindBio Therapeutics Corp. is a biotech/biopharma company. It creates novel and emerging treatments for mental health conditions and is conducting take-home Microdosing (MB22001) human clinical trials. MB22001 is its lead candidate drug, a titratable form of Lysergic Acid Diethylamide designed for take-home microdosing. It is focused on microdosing of psychedelic medicines and is advancing its... see more

Bullboard (CSE:MBIO)

View:
Post by TrevorAbeson Jun 20, 2024 11:37am

MindBio's microdosed LSD reduces depression post treatment

https://stockhouse.com/news/the-market-online-news/2024/06/20/mindbio-s-microdosed-lsd-reduces-depression-post-treatment
Comment by Smokey1958on May 26, 2024 5:12pm

RE:Enveric

Subsequent to this Enveric received the following notification: https://www.sec.gov/ix?doc=/Archives/edgar/data/890821/000149315224021096/form8-k.htm
Post by Smokey1958on May 26, 2024 5:08pm

Enveric

Here is the first document, Form 8-K, that Enveric had to submit to avoid immediate de-listing. They have complied, to no surprise, and will this have time to move forward ...positively. https://www ...more  
Comment by Smokey1958on May 26, 2024 11:15am

RE:RE:RE:Enveric doesn’t meet Nasdaq listing requirements

Here is the website on the process for delisting.  https://waterfrontonline.blog/wp-content/uploads/2022/10/delistingrules.pdf
Comment by Smokey1958on May 26, 2024 11:14am

RE:RE:Enveric doesn’t meet Nasdaq listing requirements

Make sure you don't cherry pick only that which supports your point of view??? The following is part of the overview of delisting as explained within the website below: Return to Compliance ...more  
Comment by MrForthrighton May 25, 2024 2:37pm

RE:Enveric doesn’t meet Nasdaq listing requirements

Plus they have NO cash and a HUGE debt. complete bust
Comment by Smokey1958on May 20, 2024 5:58pm

RE:RE:RE:Beware the Aussie Bullies

You might want to (a) read the whole report on sedar (b) consider the conversion of a major loan to shares (as requested by the lender) (c)  understand it's an early stage pharma company ...more  
Comment by MrForthrighton May 20, 2024 3:40pm

RE:RE:Beware the Aussie Bullies

Broke = see www.sedarplus.com, all there
Comment by Smokey1958on May 20, 2024 12:46pm

RE:Beware the Aussie Bullies

How is MBIO broke? How many aliases do you have? Where is the evidence? MBIO has the following going for it so it ain't broke, genius: * it's a startup ....so of course it has more ...more  
Post by MrForthrighton May 18, 2024 5:10pm

Beware the Aussie Bullies

They are promoting broke companies like $MBIO and $SPAI. Stay away
Post by Sleepydog24on May 14, 2024 10:55pm

The writing is on the wall

What today's news release left out is the game plan of Mindbio becoming Nazdaq listed through this deal with Enveric ... Mindbio needed a clean structured Psych company already listed and they ...more  
Comment by Smokey1958on May 14, 2024 11:34am

RE:Why Would Enveric Do This?

This may be the "link" to MBIO I suggested in the first post. According to the Enveric website their next step for this particular formulation was in looking to do an FIH (first in human ...more  
Post by Smokey1958on May 14, 2024 10:03am

Why Would Enveric Do This?

The potential in this is extraordinary for both companies. I would expect that the reasons for Enteric entering into an agreement like this is that they have a much faster path to clinical trials for ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities